Previous Article | Next Article 
Journal of Bacteriology, June 2000, p. 3394-3399, Vol. 182, No. 12
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
A Point Mutation in the mma3 Gene Is Responsible for
Impaired Methoxymycolic Acid Production in Mycobacterium
bovis BCG Strains Obtained after 1927
Marcel A.
Behr,1,*
Benjamin G.
Schroeder,2
Jacquelyn N.
Brinkman,1
Richard A.
Slayden,2 and
Clifton E.
Barry III2
McGill University Health Centre, Montreal, Canada H3G
1A4,1 and Tuberculosis Research
Section, Laboratory of Host Defenses, National Institute of Allergy
and Infectious Diseases, Rockville, Maryland 208522
Received 12 January 2000/Accepted 29 March 2000
BCG vaccines are substrains of Mycobacterium bovis
derived by attenuation in vitro. After the original attenuation (1908 to 1921), BCG strains were maintained by serial propagation in
different BCG laboratories (1921 to 1961). As a result, various BCG
substrains developed which are now known to differ in a number of
genetic and phenotypic properties. However, to date, none of these
differences has permitted a direct phenotype-genotype link. Since BCG
strains differ in their abilities to synthesize methoxymycolic acids
and since recent work has shown that the mma3 gene is
responsible for O-methylation of hydroxymycolate precursors to form
methoxymycolic acids, we analyzed methoxymycolate production and
mma3 gene sequences for a genetically defined collection of
BCG strains. We found that BCG strains obtained from the Pasteur
Institute in 1927 and earlier produced methoxymycolates in vitro but
that those obtained from the Pasteur Institute in 1931 and later all
failed to synthesize methoxymycolates, and furthermore, the
mma3 sequence of the latter strains differs from that of
Mycobacterium tuberculosis H37Rv by a point mutation at bp
293. Site-specific introduction of this guanine-to-adenine mutation
into wild-type mma3 (resulting in the replacement of
glycine 98 with aspartic acid) eliminated the ability of this enzyme to
produce O-methylated mycolic acids when the mutant was cloned in tandem
with mma4 into Mycobacterium smegmatis. These
findings indicate that a point mutation in mma3 occurred between 1927 and 1931, and that this mutant population became the
dominant clone of BCG at the Pasteur Institute.
*
Corresponding author. Mailing address: A5-156, Montreal
General Hospital, 1650 Cedar Ave., Montreal, Canada, H3G 1A4. Phone: (514) 937-6011, ext. 2815. Fax: (514) 934-8016. E-mail:
mbgq{at}musica.mcgill.ca.
Journal of Bacteriology, June 2000, p. 3394-3399, Vol. 182, No. 12
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Garcia Pelayo, M. C., Uplekar, S., Keniry, A., Mendoza Lopez, P., Garnier, T., Nunez Garcia, J., Boschiroli, L., Zhou, X., Parkhill, J., Smith, N., Hewinson, R. G., Cole, S. T., Gordon, S. V.
(2009). A Comprehensive Survey of Single Nucleotide Polymorphisms (SNPs) across Mycobacterium bovis Strains and M. bovis BCG Vaccine Strains Refines the Genealogy and Defines a Minimal Set of SNPs That Separate Virulent M. bovis Strains and M. bovis BCG Strains. Infect. Immun.
77: 2230-2238
[Abstract]
[Full Text]
-
Mackenzie, N., Alexander, D. C., Turenne, C. Y., Behr, M. A., De Buck, J. M.
(2009). Genomic Comparison of PE and PPE Genes in the Mycobacterium avium Complex. J. Clin. Microbiol.
47: 1002-1011
[Abstract]
[Full Text]
-
Wheeler, P. R., Brosch, R., Coldham, N. G., Inwald, J. K., Hewinson, R. G., Gordon, S. V.
(2008). Functional analysis of a clonal deletion in an epidemic strain of Mycobacterium bovis reveals a role in lipid metabolism. Microbiology
154: 3731-3742
[Abstract]
[Full Text]
-
Griffiths, T. A., Rioux, K., De Buck, J.
(2008). Sequence Polymorphisms in a Surface PPE Protein Distinguish Types I, II, and III of Mycobacterium avium subsp. paratuberculosis. J. Clin. Microbiol.
46: 1207-1212
[Abstract]
[Full Text]
-
Dover, L. G., Alahari, A., Gratraud, P., Gomes, J. M., Bhowruth, V., Reynolds, R. C., Besra, G. S., Kremer, L.
(2007). EthA, a Common Activator of Thiocarbamide-Containing Drugs Acting on Different Mycobacterial Targets. Antimicrob. Agents Chemother.
51: 1055-1063
[Abstract]
[Full Text]
-
Boissier, F., Bardou, F., Guillet, V., Uttenweiler-Joseph, S., Daffe, M., Quemard, A., Mourey, L.
(2006). Further Insight into S-Adenosylmethionine-dependent Methyltransferases: STRUCTURAL CHARACTERIZATION OF Hma, AN ENZYME ESSENTIAL FOR THE BIOSYNTHESIS OF OXYGENATED MYCOLIC ACIDS IN MYCOBACTERIUM TUBERCULOSIS. J. Biol. Chem.
281: 4434-4445
[Abstract]
[Full Text]
-
Spreadbury, C. L., Pallen, M. J., Overton, T., Behr, M. A., Mostowy, S., Spiro, S., Busby, S. J. W., Cole, J. A.
(2005). Point mutations in the DNA- and cNMP-binding domains of the homologue of the cAMP receptor protein (CRP) in Mycobacterium bovis BCG: implications for the inactivation of a global regulator and strain attenuation. Microbiology
151: 547-556
[Abstract]
[Full Text]
-
Belley, A., Alexander, D., Di Pietrantonio, T., Girard, M., Jones, J., Schurr, E., Liu, J., Sherman, D. R., Behr, M. A.
(2004). Impact of Methoxymycolic Acid Production by Mycobacterium bovis BCG Vaccines. Infect. Immun.
72: 2803-2809
[Abstract]
[Full Text]
-
Dinadayala, P., Lemassu, A., Granovski, P., Cerantola, S., Winter, N., Daffe, M.
(2004). Revisiting the Structure of the Anti-neoplastic Glucans of Mycobacterium bovis Bacille Calmette-Guerin: STRUCTURAL ANALYSIS OF THE EXTRACELLULAR AND BOILING WATER EXTRACT-DERIVED GLUCANS OF THE VACCINE SUBSTRAINS. J. Biol. Chem.
279: 12369-12378
[Abstract]
[Full Text]